Genomics plc is a pioneering healthcare company that is revolutionizing the field of genomics. Founded in 2014 by leading geneticists at the University of Oxford, Genomics plc uses large-scale genetic information to develop innovative precision healthcare tools and bring new insights to drug discovery. With their proprietary algorithms and databases, they can accurately link minute variations across human genomes to changes in thousands of biological measurements and disease outcomes.

This enables them to generate valuable insights for healthcare systems, clinicians, and pharmaceutical companies. In their Precision Health division, Genomics plc is at the forefront of genomic prevention, providing reliable personalized estimates of risk for common diseases well ahead of manifestation. This allows for targeted interventions and tailored screening to prevent or catch diseases early when outcomes are favorable.

Their Therapeutics division collaborates with leading pharmaceutical companies to incorporate deep understanding of human genetics into research and development for the discovery and validation of new drug targets. Backed by top investors, the Genomics team comprises over 100 scientists, engineers, and deployment specialists dedicated to turning scientific advancements into impactful healthcare solutions. Headquartered in Oxford, Genomics plc also has offices in Cambridge (UK) and Boston (US)